Scholarlink

Background <p>The Systemic Immune-Inflammation Index (SII), calculated as neutrophils × platelets / lymphocytes, reflects the interplay between systemic inflammation and immune status. Its prognostic relevance in patients undergoing transcatheter aortic valve implantation (TAVI) remains poorly understood.</p> Aim <p>To evaluate the prognostic significance of preprocedural SII in patients undergoing TAVI.</p> Methods <p>This retrospective cohort study included 1822 patients undergoing TAVI for severe aortic stenosis between 2014 and 2023 at two TAVI centers in Germany. Patients were divided into derivation and validation cohorts. Preprocedural SII was calculated from differential blood counts. In the derivation cohort, patients were stratified into tertiles based on preprocedural SII. Using receiver operating characteristics (ROC) analysis an optimized cut-off value for the validation cohort was identified to stratify patients into high- and low-risk groups. A generalized linear model (GLM) was used to identify clinical predictors of SII.</p> Results <p>In the derivation cohort, multivariate analysis showed that SII was independently associated with both major adverse cardiovascular events (MACE) (hazard ration [HR]: 1.0001 [1.00001; 1.00002], <i>p </i>= 0.020) and stroke (HR: 1.0003 [1.00002; 1.00004], <i>p</i> &lt; 0.001). In the GLM, SII positively correlated with age (<i>p</i> = 0.013) and C-reactive protein (<i>p</i> &lt; 0.001), and inversely with mean aortic gradient (<i>p</i> = 0.022) and hemoglobin (<i>p</i> = 0.011). In the external validation cohort, high risk patients (cut-off &gt; 1204) showed an increased risk for one-year all-cause mortality (HR: 2.19 [1.59; 3.02], <i>p </i>&lt; 0.001).</p> Conclusion <p>Higher preprocedural SII was independently associated with increase rates of MACE and stroke at one-year following TAVI. A SII cut-off of 1204 effectively stratifies patients into high- and low-risk groups and may provide additional value for preprocedural risk stratification.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Preprocedural Systemic Immune-Inflammation Index as a marker of risk for major adverse cardiac events and stroke after transcatheter aortic valve implantation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月2日

查看全文
  • Finn Syryca,
  • Johannes Krefting,
  • Costanza Pellegrini,
  • Tobias Rheude,
  • N. Patrick Mayr,
  • Charlotte Salzmann,
  • Fabian Starnecker,
  • Moritz von Scheidt,
  • Zsuzsanna Wolf,
  • Stefan Holdenrieder,
  • Thorsten Kessler,
  • Hendrik B. Sager,
  • Teresa Trenkwalder,
  • Salvatore Cassese,
  • Heribert Schunkert,
  • Adnan Kastrati,
  • Erion Xhepa,
  • Hendrik Ruge,
  • Markus Krane,
  • Michael Joner,
  • Christian Graesser,
  • Hector A. Alvarez-Covarrubias

摘要

Background

The Systemic Immune-Inflammation Index (SII), calculated as neutrophils × platelets / lymphocytes, reflects the interplay between systemic inflammation and immune status. Its prognostic relevance in patients undergoing transcatheter aortic valve implantation (TAVI) remains poorly understood.

Aim

To evaluate the prognostic significance of preprocedural SII in patients undergoing TAVI.

Methods

This retrospective cohort study included 1822 patients undergoing TAVI for severe aortic stenosis between 2014 and 2023 at two TAVI centers in Germany. Patients were divided into derivation and validation cohorts. Preprocedural SII was calculated from differential blood counts. In the derivation cohort, patients were stratified into tertiles based on preprocedural SII. Using receiver operating characteristics (ROC) analysis an optimized cut-off value for the validation cohort was identified to stratify patients into high- and low-risk groups. A generalized linear model (GLM) was used to identify clinical predictors of SII.

Results

In the derivation cohort, multivariate analysis showed that SII was independently associated with both major adverse cardiovascular events (MACE) (hazard ration [HR]: 1.0001 [1.00001; 1.00002], p = 0.020) and stroke (HR: 1.0003 [1.00002; 1.00004], p < 0.001). In the GLM, SII positively correlated with age (p = 0.013) and C-reactive protein (p < 0.001), and inversely with mean aortic gradient (p = 0.022) and hemoglobin (p = 0.011). In the external validation cohort, high risk patients (cut-off > 1204) showed an increased risk for one-year all-cause mortality (HR: 2.19 [1.59; 3.02], p < 0.001).

Conclusion

Higher preprocedural SII was independently associated with increase rates of MACE and stroke at one-year following TAVI. A SII cut-off of 1204 effectively stratifies patients into high- and low-risk groups and may provide additional value for preprocedural risk stratification.

Graphical Abstract